682 related articles for article (PubMed ID: 25665947)
21. Long-term outcome of portomesenteric vein invasion and prognostic factors in pancreas head adenocarcinoma.
Jeong J; Choi DW; Choi SH; Heo JS; Jang KT
ANZ J Surg; 2015 Apr; 85(4):264-9. PubMed ID: 24641800
[TBL] [Abstract][Full Text] [Related]
22. Pancreaticoduodenectomy with mesentericoportal vein resection for adenocarcinoma of the pancreatic head.
Carrère N; Sauvanet A; Goere D; Kianmanesh R; Vullierme MP; Couvelard A; Ruszniewski P; Belghiti J
World J Surg; 2006 Aug; 30(8):1526-35. PubMed ID: 16855797
[TBL] [Abstract][Full Text] [Related]
23. Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.
Fuhrman GM; Leach SD; Staley CA; Cusack JC; Charnsangavej C; Cleary KR; El-Naggar AK; Fenoglio CJ; Lee JE; Evans DB
Ann Surg; 1996 Feb; 223(2):154-62. PubMed ID: 8597509
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance of portal-superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head cancer.
Han SS; Park SJ; Kim SH; Cho SY; Kim YK; Kim TH; Lee SA; Woo SM; Lee WJ; Hong EK
Pancreas; 2012 Jan; 41(1):102-6. PubMed ID: 21775914
[TBL] [Abstract][Full Text] [Related]
25. Should the portal vein be routinely resected during pancreaticoduodenectomy for adenocarcinoma?
Turrini O; Ewald J; Barbier L; Mokart D; Blache JL; Delpero JR
Ann Surg; 2013 Apr; 257(4):726-30. PubMed ID: 22968078
[TBL] [Abstract][Full Text] [Related]
26. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
[TBL] [Abstract][Full Text] [Related]
27. One Hundred Pancreatectomies with Venous Resection for Pancreatic Adenocarcinoma.
Dumitrascu T; Martiniuc A; Brasoveanu V; Stroescu C; David L; Dima S; Stanciulea O; Ionescu M; Popescu I
Chirurgia (Bucur); 2018; 113(3):363-373. PubMed ID: 29981667
[No Abstract] [Full Text] [Related]
28. Significance of Portal Vein Invasion and Extent of Invasion in Patients Undergoing Pancreatoduodenectomy for Pancreatic Adenocarcinoma.
Roch AM; House MG; Cioffi J; Ceppa EP; Zyromski NJ; Nakeeb A; Schmidt CM
J Gastrointest Surg; 2016 Mar; 20(3):479-87; discussion 487. PubMed ID: 26768008
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of resections for pancreatic adenocarcinoma with suspected venous involvement: a single center experience.
Michalski CW; Kong B; Jäger C; Kloe S; Beier B; Braren R; Esposito I; Erkan M; Friess H; Kleeff J
BMC Surg; 2015 Aug; 15():100. PubMed ID: 26296752
[TBL] [Abstract][Full Text] [Related]
30. Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates.
Fujii T; Nakao A; Yamada S; Suenaga M; Hattori M; Takami H; Inokawa Y; Kanda M; Sugimoto H; Nomoto S; Murotani K; Kodera Y
Surgery; 2015 Apr; 157(4):708-15. PubMed ID: 25704426
[TBL] [Abstract][Full Text] [Related]
31. Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension.
Bachellier P; Rosso E; Fuchshuber P; Addeo P; David P; Oussoultzoglou E; Lucescu I
Surgery; 2014 Mar; 155(3):449-56. PubMed ID: 24462078
[TBL] [Abstract][Full Text] [Related]
32. Does portal-superior mesenteric vein invasion still indicate irresectability for pancreatic carcinoma?
Ramacciato G; Mercantini P; Petrucciani N; Giaccaglia V; Nigri G; Ravaioli M; Cescon M; Cucchetti A; Del Gaudio M
Ann Surg Oncol; 2009 Apr; 16(4):817-25. PubMed ID: 19156463
[TBL] [Abstract][Full Text] [Related]
33. International Study Group of Pancreatic Surgery type 3 and 4 venous resections in patients with pancreatic adenocarcinoma:the Paoli-Calmettes Institute experience.
Al Faraï A; Garnier J; Ewald J; Marchese U; Gilabert M; Moureau-Zabotto L; Poizat F; Giovannini M; Delpero JR; Turrini O
Eur J Surg Oncol; 2019 Oct; 45(10):1912-1918. PubMed ID: 31186204
[TBL] [Abstract][Full Text] [Related]
34. Defining venous involvement in borderline resectable pancreatic cancer.
Chun YS; Milestone BN; Watson JC; Cohen SJ; Burtness B; Engstrom PF; Haluszka O; Tokar JL; Hall MJ; Denlinger CS; Astsaturov I; Hoffman JP
Ann Surg Oncol; 2010 Nov; 17(11):2832-8. PubMed ID: 20725860
[TBL] [Abstract][Full Text] [Related]
35. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
Martin RC; Scoggins CR; Egnatashvili V; Staley CA; McMasters KM; Kooby DA
Arch Surg; 2009 Feb; 144(2):154-9. PubMed ID: 19221327
[TBL] [Abstract][Full Text] [Related]
36. Portal vein resection in pancreatic head carcinoma. Part 2: Clinical significance.
Tuech JJ; Pessaux P; Arnaud JP
Hepatogastroenterology; 2001; 48(39):888-91. PubMed ID: 11462949
[TBL] [Abstract][Full Text] [Related]
37. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy.
Capussotti L; Massucco P; Ribero D; Viganò L; Muratore A; Calgaro M
Arch Surg; 2003 Dec; 138(12):1316-22. PubMed ID: 14662531
[TBL] [Abstract][Full Text] [Related]
38. Significance of pathological positive superior mesenteric/portal venous invasion in pancreatic cancer.
Tewari M
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):572-578. PubMed ID: 27919845
[TBL] [Abstract][Full Text] [Related]
39. Outcome of superior mesenteric-portal vein resection during pancreatectomy for borderline ductal adenocarcinoma: results of a prospective comparative study.
Selvaggi F; Mascetta G; Daskalaki D; dal Molin M; Salvia R; Butturini G; Cellini C; Bassi C
Langenbecks Arch Surg; 2014 Jun; 399(5):659-65. PubMed ID: 24777762
[TBL] [Abstract][Full Text] [Related]
40. The importance of invasion and resection of superior mesenteric and portal veins in adenocarcinoma of the pancreas.
Aktekin A; Küçük M; Odabaşi M; Muftuoglu T; Gürleyik G; Özkara S; Aker F; Saglam A
Hepatogastroenterology; 2013; 60(125):1194-8. PubMed ID: 23803382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
